Synchronization of ovulation and fertility in weaned sows treated with intravaginal triptorelin is influenced by timing of administration and follicle size.
A 100 μg dose of triptorelin was tested for synchronizing ovulation in sows. In Experiment 1, conducted in April through June, sows (n = 125) were assigned to Control (untreated), TG-96 (Triptorelin Gel (TG) given intravaginally at 96 h post-weaning), or TG-E (given intravaginally at estrus). To optimize AI timing, sows were inseminated at 2 and 26 h after estrus for Control and TG-E and at 8 and 32 h following TG-96. Ovulation by 48 h post-treatment tended to be affected by treatment (P = 0.08) and more (P < 0.05) TG-96 sows ovulated (57.9%) compared to Controls (34.2%), but TG-E (45.1%) did not differ (P > 0.10). Duration of estrus was reduced (P < 0.005) in TG-96 (51 h) and TG-E (58 h) compared to Controls (65 h). There was no treatment effect on farrowing rate (71%) or total born (10.4). Average follicle size <6.5 mm at 96 h after weaning was associated with reduced (P < 0.01) estrus, ovulation and farrowing rate. Experiment 2 was conducted in August through September using 503 weaned sows. The TG-96 treatment reduced duration of estrus (P = 0.03), but treatment did not affect estrus expression, farrowing rate or total pigs born. In conclusion, use of a 100 μg dose of triptorelin intravaginally at 96 h or at estrus advanced ovulation and when used with timed insemination, resulted in similar farrowing rates and litter sizes comparable to sows mated based on estrus. However, ovulation induction and timed AI success may benefit from an approach that ensures sows have adequate follicle development at time of treatment.
Department of Animal Science, University of Illinois, 360 Animal Science Lab, 1207 West Gregory Drive, MC-630 Urbana, Illinois, USA. rknox@illinois.edu
R V
RV
Knox
K L
KL
Willenburg
S L
SL
Rodriguez-Zas
D L
DL
Greger
H D
HD
Hafs
M E
ME
Swanson
D000282:Administration, Intravaginal; D000818:Animals; D048429:Cell Size / Q000187:drug effects; D004334:Drug Administration Schedule; D004973:Estrus Synchronization / Q000379:methods*; D005260:Female; D005306:Fertilization / Q000187:drug effects* / Q000502:physiology; D008186:Luteolytic Agents / Q000008:administration & dosage; D006080:Ovarian Follicle / Q000166:cytology* / Q000187:drug effects / Q000502:physiology; D010062:Ovulation Induction / Q000379:methods; D013552:Swine / Q000502:physiology; D013997:Time Factors; D017329:Triptorelin Pamoate / Q000008:administration & dosage*; D014886:Weaning
D008186:Luteolytic Agents; D017329:Triptorelin Pamoate